State Epidemiologist Issues Information on Severe Influenza in Pregnancy and FDA Emergency Use Authorization for Peramivir

State Epidemiologist Megan Davies, MD, issued a one-page guidance on Tuesday for physicians, Severe Influenza in Pregnancy: Consultation and Reporting (click the title to read the guidance).  The guidance provides information for clinical consultation and resources, along with guidance on monitoring and reporting severe influenza infections in pregnant and postpartum women.

Dr. Davies also distributed a message from the CDC, issued on October 25, 2009, concerning the US Food and Drug Administration (FDA) issuing an emergency use authorization (EUA) for the use of the investigational antiviral drug Peramivir intravenous (IV) in certain adult and pediatric patients with confirmed or suspected 2009 H1N1 influenza infection, who are admitted to a hospital. Read the CDC message here.

Back to Bulletin


Share this Post